ArticleQuality & quantity2022
Looking for COVID side effects in the EU through the analysis of health and behavioural profiles.
Article in Quality & quantity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
More than two years after the great outbreak of COVID suffered in almost the whole world, and in particular in Europe, we have gradually learned about the direct effects of this virus on our health and what consequences it can have if we become infected. However, this pandemic also had great economic and social consequences that affected people in an indirect way, which we can call COVID side effects. In this work we carried out an innovative type of analysis based on the concept of archetypoids in order to find extreme observations in a database of mixed-type data and used them to classify individuals yielding to different health and behavioural profiles in coping with the COVID outbreak in the EU. We use data from the first COVID-19 Survey of the SHARE project (Survey on Health, Aging and Retirement in Europe). The resulting profiles are easier to interpret than others based on central observations, and help to understand how the situations of restrictions and lock-downs affected people since the outbreak of the pandemic. Another key point of the work was to analyse how determinant are some aspects such as gender, age group or even geographical location in how each person experienced the pandemic. The method that we propose is wide enough to be used in other health and wellbeing surveys.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.